ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VER Vernalis

6.17
0.00 (0.00%)
04 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vernalis LSE:VER London Ordinary Share GB00B3Y5L754 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.17 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vernalis Share Discussion Threads

Showing 2301 to 2322 of 3850 messages
Chat Pages: Latest  94  93  92  91  90  89  88  87  86  85  84  83  Older
DateSubjectAuthorDiscuss
25/8/2009
11:44
Lets hope it gets noticed by other investors!
fhmktg
25/8/2009
11:16
very nice write up by GCI, thanks for that investinggarden
shaid1
25/8/2009
11:09
Buy recommendation from Growth Company Investor
investinggarden
25/8/2009
09:56
cest

well said, denarii has come on this thread to disrupt it. he does the same on other threads.

shaid1
25/8/2009
09:31
Don't remember Glaxo investing in either of those. DYOR and maybe you will find out.
cestnous
24/8/2009
16:53
Shaid. See below but they are not necessarily recommendations!!!

RHEP
VRP
CZA
VLK
EGX
APF
PRL
ANR
VIY
EROS

Losing bigtime in MTA and TMAN from last year. But the former is coming back and if the latter re-lists it could yet come good.

And about a dozen starter posns. in others.

cestnous
24/8/2009
16:38
cest

good lad.

what else u into?

shaid1
24/8/2009
16:31
In case anyone is wondering, this slight drop is not due to the Insti selling;

The movement is due to the |
| | increase in the issued share |
| | capital as a result of the shares |
| | issued to GSK, announced on 20 |
| | August 2009.

cestnous
19/8/2009
12:06
nous

agreed, i think this and eros will be huge inside 12 months.

Im also in UNIQ and think that will do very very well. Rainmaker and 2baffled on there are very very good posters.

shaid1
19/8/2009
12:03
Looks like its just me and you Shaid. Well why share the profits ?
See you'r into EROS. That's my biggest holding at the moment. I think we are both going to be rich.

cestnous
18/8/2009
20:53
hopefully we'll be in before the herd arrives. i hope they arrive at 300p plus. lol
shaid1
18/8/2009
20:53
Nous,

i read it too and agree it was hugely bullish, if these can get to around 500p within 12 months we'll both be quids in imho.

GSK taking shares at 87p is a massive bonus imho.

shaid1
18/8/2009
16:32
Yes I have Shaid1. It was indeed bullish, but I am afraid that I do not go a lot on charts analysis. The author however seems to have been taking the other good things in to account and after watching for a long time, this just smells to me like it is developing momentum, especially at a time of uncertainty, when many authorities seem to see the pharma sector as 'defensive'.

Best of luck

Nous

cestnous
18/8/2009
16:26
cestnous

have you read the shares article from last week...it was hugely bullish.

shaid1
18/8/2009
16:20
Well that's me in; watched for a while and hopefully now its going somewhere!
cestnous
17/8/2009
12:49
virtually all buys today spread is very very tight now.

Shares article was very positive last thursday.

shaid1
17/8/2009
08:20
free stock charts from www.advfn.com


TIPPED IN SHARES MAGAZINE ON 13 AUGUST TO REACH 218p THEN MOVE ONTO 498p



6th august 09 - Under the terms of the deal Vernalis will receive $6 million upon signing (including a $3 million equity subscription by GSK for 2,040,542 new ordinary shares in Vernalis at a subscription price of 87 pence per share) and is
eligible to earn up-front and potential milestone payments in excess of $200
million and up to double digit royalties based on worldwide sales of an oncology
product. Further milestones and royalties could be earned should products
against the target be developed for indications outside of oncology.

shaid1
06/8/2009
17:23
news seems to be out in many different forms today..

Drug developer Vernalis has signed an exclusive collaboration, option and license agreement with GlaxoSmithKline relating to a Vernalis research programme against an undisclosed oncology target. Under the terms of the deal, Vernalis will receive $6m upon signing (including a $3m equity subscription by GSK for 2.04m shares at 87p per share) and is eligible to earn up-front and potential milestone payments in excess of $200m.

4screws
06/8/2009
16:01
some interesting trades shwon as sells, probably buys 2173x92 at a time ...resulting in over £30k trades.... now reduced my loss to 46% of investment, pyschologivcally under that 50%, so will hold and hold and hold...how long too break even...welll have beeen here through thick and thin for years and in 6 months the new team seem to be performing very well.

I hold.

4screws
06/8/2009
08:20
Rock solid results and a decent collaboration. Hopefully the tie up with give VER more inches in the press when trial results are announced.

Nothing extrordinary, but have come to expect that from this stock.

vow
06/8/2009
08:20
I would not like to suggest to anyone whether to buy into any share and everyone should DYOR.....but the news this morning is good.......

....and with a name like yours....being lucky.....

jwoolley
06/8/2009
08:17
Yes, I am here, but I am new to this thread so probably not much use to you.

Was just trying to decide wether to buy in.

lucky_lady
Chat Pages: Latest  94  93  92  91  90  89  88  87  86  85  84  83  Older